Background: Qizhi Xiangfu Pills (QXPs) are a traditional Chinese medicine (TCM) used clinically for qi stagnation and blood stasis. The current quality control of QXPs in the ministry standards and the reported literature is minimal, and requires improvement. Objective: This study aimed to analyze and determine the active ingredients in QXPs for its overall evaluation. Methods: In this study, a quantitative analysis of multi-components by a single marker (QAMS) method was established to simultaneously determine caryophyllene oxide, cyperotundone, ligustilide, and α-cyperone in QXPs by GC. Moreover, the GC fingerprints of 22 batches of samples were also established, and the common peaks were initially identified by GC–MS, then classified in various dimensions using chemometric methods, and the main markers causing the discrepancies between groups were analyzed by orthogonal partial least-squares discrimination analysis (OPLS-DA). Results: Compared with an internal standard method (ISM), the determination results obtained by QAMS had no significant difference. Twenty-two common peaks were distinguished in the fingerprint of 22 batches of QXPs, 17 of which were identified, and the similarity of the fingerprints was greater than 0.898. The 22 batches of QXPs were roughly divided into 3 categories, and 12 main markers causing the discrepancies were discovered. Conclusion: The established QAMS method combined with the GC fingerprint and chemometrics is convenient and feasible, which helps to improve the quality evaluation of QXPs and provides a demonstration for the related study of compound preparations and single herbs. Highlights: QAMS combined with a GC fingerprint and chemometrics method was established to evaluate the quality of QXPs for the first time.
Based on high performance liquid chromatography with the diode array detector (HPLC-DAD), a new strategy for simultaneous determination of ten bioactive ingredients in Lianhua Qingwen capsule (LHQW) was developed for comprehensive quality assessment of LHQW. In this work, with rhein regarded as the internal reference substance (IRS), the relative correction factors (RCFs) of neochlorogenic acid, amygdalin, chlorogenic acid, forsythoside A, quercitrin, phillyin, glycyrrhizic acid, isoforsythiaside, and (+) pinoresinol-β-D-glucoside were calculated for simultaneous determination of ten bioactive ingredients. More importantly, compared to previous work, the simultaneous determination of the content of ten pharmacologically important active ingredients at one detection wavelength with only one reference substance has been achieved. Based on the contents of ten bioactive ingredients, the quality of the 20 batches of LHQW samples was further analyzed by chemical recognition patterns method. Ten bioactive ingredients showed a good linear relationship in their respective concentration ranges (r ≥ 0.999). The relative standard deviations (RSDs) of precision (≤4.62%), stability (≤4.04%), repeatability (≤3.87%), and the average recovery of ten bioactive components (99.8%∼104.1%) demonstrated the QAMS developed for LHQW which had good durability. The correlation coefficient ( ) showed that no significant difference existed in the results of QAMS and external standard method (ESM). Hierarchical clustering analysis (HCA) divided samples into three main groups. Radar plot analysis and principal component analysis (PCA) found some quality differences existed between the three groups of samples. Orthogonal partial least-squares discrimination analysis (OPLS-DA) showed that forsythoside A could be used as the primary marker responsible for the quality differences. In conclusion, the established QAMS method combined with chemometric analysis can simultaneously determine the content of 10 active components and comprehensively evaluate the quality of different batches of LHQW. It can provide scientific basis and reference of quality consistency evaluation for the formulation manufacturers and drug regulatory authorities.
1 January 2026 in Journal of Analytical Methods in Chemistry
Albiziae Flos (AF) is a traditional Chinese medicine with an extensive historical background. This study presented an integrated approach combining headspace–gas chromatography–mass spectrometry (HS–GC–MS), chemometrics, and network pharmacology to comprehensively evaluate the volatile components of AF and explore their potential antidepressant mechanisms. A total of 34 volatile compounds were identified through HS–GC–MS analysis. Fingerprint assessment revealed high consistency among 16 batches (similarity: 0.790–0.998), while chemometric analysis successfully discriminated samples from different geographical origins. Network pharmacology screening identified 15 active components and 131 potential targets, revealing multicomponent, multitarget characteristics of AF’s antidepressant effects. Molecular docking simulations demonstrated strong binding affinity between linalool oxide configurations and 12 core targets, primarily through hydrogen bonding and hydrophobic interactions. This work lies in its comprehensive investigation of AF’s volatile components using an integrated analytical–pharmacological approach, providing both a methodological framework for quality assessment and mechanistic insights for antidepressant drug development. Our findings established scientific foundations for quality control of AF and revealed its potential antidepressant mechanisms through multiple pathways.